We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+3.8%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.74%
5 Year Est. Return
+136.38%
10 Year Est. Return
+1,412.31%
AUM
$22.6B
AUM Growth
+$4.98B
Cap. Flow
+$4.53B
Cap. Flow %
20.05%
Top 10 Hldgs %
40.91%
Holding
2,774
New
620
Increased
589
Reduced
714
Closed
789

Sector Composition

Rank Sector Weight
1 Technology 11.68%
2 Industrials 8.46%
3 Financials 6.56%
4 Consumer Discretionary 5.98%
5 Healthcare 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WK icon
1326
Workiva
WK
$3.54B
$597K ﹤0.01%
6,927
-11,218
-62% -$993K
EMIS
1327
Emmis Acquisition Corp
EMIS
$161M
$597K ﹤0.01%
+59,900
New +$597K
BIO icon
1328
Bio-Rad Laboratories Class A
BIO
$9.42B
$597K ﹤0.01%
1,971
-299
-13% -$93.3K
LATA
1329
Galata Acquisition Corp II
LATA
$233M
$596K ﹤0.01%
+59,930
New +$597K
BBBY
1330
Bed Bath & Beyond
BBBY
$442M
$595K ﹤0.01%
+108,885
New +$790K
NSIT icon
1331
Insight Enterprises
NSIT
$4.38B
$585K ﹤0.01%
+7,182
New +$674K
MYGN icon
1332
Myriad Genetics
MYGN
$312M
$584K ﹤0.01%
95,035
+39,586
+71% +$287K
VOD icon
1333
Vodafone
VOD
$37.4B
$581K ﹤0.01%
44,008
+32,728
+290% +$396K
VFC icon
1334
CALL
VF Corp
VFC
$5.89B
$579K ﹤0.01%
+32,000
New +$519K
VFC icon
1335
PUT
VF Corp
VFC
$5.89B
$579K ﹤0.01%
+32,000
New +$519K
GLIBK
1336
Liberty Capital Corp Series C GCI Group Common Stock
GLIBK
$958M
$578K ﹤0.01%
15,543
+2,740
+21% +$96.2K
CCI icon
1337
Crown Castle
CCI
$32.2B
$576K ﹤0.01%
6,484
-264,725
-98% -$24.3M
NB
1338
NioCorp Developments
NB
$780M
$576K ﹤0.01%
108,630
-158,670
-59% -$1.09M
NGNE icon
1339
Neurogene
NGNE
$712M
$575K ﹤0.01%
+27,894
New +$694K
CHECU
1340
Chenghe Acquisition III Co Units
CHECU
$574K ﹤0.01%
+57,164
New +$572K
AER icon
1341
AerCap
AER
$23.8B
$573K ﹤0.01%
3,987
-12,090
-75% -$1.6M
LNTH icon
1342
Lantheus
LNTH
$6.59B
$573K ﹤0.01%
+8,610
New +$501K
MZTI
1343
The Marzetti Company
MZTI
$3.11B
$570K ﹤0.01%
3,464
-4,882
-58% -$815K
LCII icon
1344
LCI Industries
LCII
$2.65B
$567K ﹤0.01%
4,669
-8,960
-66% -$953K
SWKS icon
1345
Skyworks Solutions
SWKS
$10.6B
$566K ﹤0.01%
8,928
-314,776
-97% -$22M
PEBO icon
1346
Peoples Bancorp
PEBO
$1.47B
$565K ﹤0.01%
+18,819
New +$559K
TRN icon
1347
Trinity Industries
TRN
$2.38B
$565K ﹤0.01%
21,359
+888
+4% +$24.1K
VFF icon
1348
Village Farms International
VFF
$253M
$561K ﹤0.01%
+153,719
New +$535K
CRML icon
1349
Critical Metals Corp
CRML
$1.06B
$560K ﹤0.01%
+80,661
New +$880K
CVCO icon
1350
Cavco Industries
CVCO
$4.55B
$559K ﹤0.01%
947
-37,770
-98% -$21.4M

Similar funds

Schonfeld Strategic Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Schonfeld Strategic Advisors held 2,774 positions worth $22.6B, up 28% from $17.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Schonfeld Strategic Advisors deployed $4.53B of net new capital in Q4 2025, opening 620 new positions and adding to 589 existing holdings. Its largest new stake was Medline Inc: 1,945,050 shares worth $81.7M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Eli Lilly, an estimated $213M trimmed.

  • Schonfeld Strategic Advisors's largest Q4 2025 buy was Medline Inc: 1,945,050 shares worth $81.7M.
  • Schonfeld Strategic Advisors added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $5.4B increase.
  • Schonfeld Strategic Advisors's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $213M.
  • Schonfeld Strategic Advisors fully exited Southwest Airlines in Q4 2025, selling an estimated $73.9M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 41% of its $22.6B portfolio in Q4 2025.
  • Schonfeld Strategic Advisors opened 620 new positions and closed 789 in Q4 2025.
  • Schonfeld Strategic Advisors's portfolio value rose 28% quarter-over-quarter to $22.6B.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.